Psychedelic Invest Podcast

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Matthew Helt, a certified psychedelic integration coach and CEO of Prairiesattva.

As an ICF-certified PCC growth and development coach, psychedelic integration coach, and CEO of Prairiesattva, Matt works with startup founders and other leaders who recognize that something's missing in their lives and in their work. 

Matt also coaches people who've been called to use plant-medicine and are in need of integrating what they've learned into their lives.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Darryl Hudson, the Co-Founder and CIO of GoodCap Pharmaceuticals.

Darryl Hudson is a PhD in Molecular Biology and Genetics and is active in the Hemp, Cannabis and Psychedelic Drug Development Industries.

GoodCap Pharmaceuticals Inc. (goodcap.com) is a leading Canadian drug development company devoted to harnessing and applying the physical and mental health benefits of mushrooms and mushroom-derived compounds. GoodCap is a leader in formulation, research and development of psilocybin-based therapeutic products and is dedicated to discovering natural therapies for inflammatory disorders and mental health conditions.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Christi Myers, the author of The Founder and CEO of Flow Integrative.

Christi is a passionate advocate for the human potential and the transformative benefits of psychedelic wellness. As the Founder and CEO of Flow Integrative, she has dedicated herself to creating a platform that supports individuals on their journey towards healing and self-discovery.

Christi embodies resilience and determination. Her experiences have shaped her into a compassionate and empathetic guide for those seeking transformational healing.

Having served as a Tenure Professor and Assistant Director of Emergency Medicine for over 20 years, Christi brings a wealth of expertise to her work. Her focused training credentials enable her to "help the help," providing vital supportive services for front-line workers and service men and women who face chronic and complex trauma in their devoted line of work.

Christi has undergone thorough training in integrative treatment modalities, including psychotherapy, recognizing the invaluable role that psychedelics like Ketamine hold in unlocking deep and successful treatment outcomes. Her comprehensive approach combines evidence-based practices with the power of psychedelics to create a holistic and transformative healing experience.

As a Licensed Paramedic and Certified Integrative Mental Health Professional, Christi possesses the skills and knowledge to provide exceptional care. Additionally, she is certified as a provider of Neurogen Brain Balancing, enhancing her ability to address the complexities of the human mind.

Christi's commitment to continuous growth and education is evident in her certifications in Nutritional and Integrative Medicine for Mental Health Professionals, as well as Compassion Fatigue Training for Healthcare, Mental Health, and Care Professionals. This dedication allows her to provide comprehensive support and address the unique needs of individuals on their healing journeys.

With a Master of Science in Leadership, a Bachelor of Science in Public Safety Administration, and an Associate's degree in Paramedic & Fire Technology, Christi's academic achievements reflect her drive to excel and make a positive impact in the field of psychedelic wellness.

Through her work as a Psychedelic Consultant and Facilitator, Christi Myers is changing lives and empowering individuals to access their innate capacity for healing and personal growth. Her role as the Founder and CEO of Flow Integrative amplifies her vision of a world where psychedelic wellness is embraced, and individuals can unlock their highest potential.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Jennifer Chesak, the author of The Psilocybin Handbook for Women.

Jennifer is the author of the forthcoming book "Psilocybin for Women," to be published by Ulysses Press and distributed by Simon & Schuster in 2023.

She is a Nashville-based freelance journalist, editor, fact-checker, and adjunct professor with more than two decades of experience. She earned her Master of Science in Journalism from Northwestern University's Medill. Her writing has appeared in Washington Post, The Daily Beast, Healthline, Verywell, Greatist, Prevention, Runner’s World, Trail Runner, Women’s Running, Health, Better Homes and Gardens, Real Simple, and more. She also serves on Healthline’s Medical Integrity Team. In addition to editorial work, her cornucopia of clips showcases a robust lineup of content marketing for several global and national brands.

Teaching is also a passion for Jennifer. She is as an adjunct professor at Belmont University, where she teaches copyediting, nonfiction and technical editing, and media studies. In addition to mentoring students in Middle Tennessee State University's certificate in writing program (MTSU Write), Jennifer is also the managing editor of the university’s literary magazine SHIFT. And she enjoys teaching evening and weekend workshops through Nashville's literary nonprofit The Porch.

Welcome to the fourth season of the Psychedelic Invest Podcast! It's great to be back!

On the season premiere episode, host Bruce Eckfeldt is joined by James Gilligan, the CEO of Tryp Therapeutics.

Jim received his Ph.D. in Pharmacology and Toxicology from the University of Connecticut; he continued his post graduate education at the Roche Institute of Molecular Biology

Following his postdoc, Jim was a co-founder of Unigene Labs, which became experts in the development of peptide based therapeutics. During his tenure at Unigene he oversaw the entire spectrum of drug development activities, including pharmacology and preclinical activities, CMC, clinical Phase I-III, as well as US and international regulatory strategies.

Jim transitioned from R&D to business development (BD) and during this time obtained a Masters in International Business from Seton Hall University (South Orange, NJ). As VP for product and business development he established a biotech joint venture in China. He was responsible for executing numerous feasibility and licensing deals with the Pharma Industry. As part of his BD responsibilities he worked frequently with investment bankers, venture capitalists, and brokers.

Following his time at Unigene Jim was a co-founder and CSO of Tarsa Therapeutics.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Melissa Lavasani of Psychedelic Medicine Coalition and Decriminalize Nature DC. 

Melissa Lavasani is the Founder and CEO of Psychedelic Medicine Coalition, Chairwoman of Decriminalize Nature DC, and the proposer of the historic winning ballot measure Initiative 81: The Entheogenic Plant and Fungus Policy Act of 2020.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfedlt is joined by Fraser Johnston of Entheotech and PsyDelve. 

After graduating from the University of Edinburgh BSc, Fraser emigrated to Canada and began scaling digital education and e-commerce platforms globally. He then became the Program Lead at one of the top tech incubators in Canada, Accelerate Okanagan (AO).

During his time at AO he helped hundreds of businesses scale through innovative program design, strategic planning and detailed operational reviews. A pioneer in the biotech industry, Fraser was inspired by his own personal healing journey to amass the world’s largest catalog of psilocybin mushroom strains to bring these powerful natural medicines to the world. His vision to inspire healthy and cooperative communities is behind everything EntheoTech does.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfedlt is joined by Samuel Becht of Deliqs. 

Samuel Becht is an entrepreneur building a digital ecosystem for psychedelic care to optimize psychedelic experiences, health outcomes, and research. He is the Founder of Deliqs.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfedlt is joined by Carina Cunha of Santori. 

Bjorn Hansen is the founder of Satori - a self-actualization platform to help people overcome trauma and integrate lessons from higher states of consciousness.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfedlt is joined by Bjorn Hansen and Nathaniel Morris of Intiem. 

Bjorn Hansen is the CEO of Intiem. An accomplished entrepreneur with a background in both pharmaceuticals and electrical engineering, Bjorn is passionate about the potential for cannabis, psychedelics, and AI to transform the sexual wellness space.

Nathaniel Morris is the Chief Innovation Officer of Intiem. With more than 20 years of experience, Nathaniel is a cannabis and psychedelic SME profiled on PBS, MSNBC, and The Discovery Channel, and author of Transforming Orgasms with Psychedelics, Cannabis & Science.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfedlt is joined by Peter Grinspoon. 

Peter Grinspoon is a primary care doctor and medical cannabis specialist at Harvard Medical School for 25 years, as well as a certified Physician Coach for the MGH Physician Center for Well-being. He is an author ("Seeing Through the Smoke: A Cannabis Specialist Untangles the Truth About Marijuana", Prometheus). He is a medical and scientific consultant in the cannabis industries, with a focus on education.

He is also a Board Member of the Advocacy Group 'Doctors For Cannabis Legalization' which is working toward cannabis legalization and social justice. 

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt welcomes both Eric and David Rahn of Rahn & Associates.

Rahn & Associates offers business insurance coverage in highly-regulated industries like cannabis and psychedelics. Their latest division positioned for the psychedelics industry is called PSYINS.

Eric is a highly specialized insurance broker and risk management professional with over 30 years of experience providing tailor-made, hard-to-place insurance coverage to domestic and multinational public and private corporations, closely held family businesses, and high-net-worth individuals.

Eric stays ahead of the curve on industry trends, regulations, and resources to match his clients with premier insurance products that fit their precise needs and budget. He has built numerous long-lasting relationships with top global insurance partners, as well as legal, finance, and accounting professionals, to lead complex insurance deals that protect businesses from the biggest risks and challenges they face today.

A graduate of Babson College School of Entrepreneurial Studies, Eric held several executive positions in highly regulated industries, including maritime and casino/gaming, prior to starting his own firm, and leverages his extensive knowledge of corporate business practices to provide C-Suite Executives' critical risk management strategies that fully protect and safeguard themselves and their businesses

In this episode, Yuriy talks about his inspiration and why he feels so passionate about the intersection between technology and mental health.

David is a specialized insurance and risk management professional who assists companies operating in highly regulated industries to minimize their risks and access critical coverages to safeguard their businesses.

As a Bespoke Insurance Broker with strong analytical skills, he performs detailed risk assessments for both start-up and established public and private companies, and develops customized strategies and solutions to ensure their businesses and C-suite executives are fully protected.

Upon graduating from Lynn University, David launched his career in digital marketing and technology before transferring his skill sets to Rahn & Associates in 2016. Most recently, he was the Southeast Territory Manager for CannGen Insurance Services, a position that enabled him to bridge and strengthen the broker-carrier relationship.

David’s unique experience having worked on both the broker and carrier side of the business and his profound ability to understand a company’s risks and match it to the right coverages is a tremendous advantage for difficult-to-insure businesses operating in high-risk industries, such as Maritime, Cannabis and Psychedelic Medicine. He leverages his strong relationships with the world's leading insurance carriers and knowledge of all the various coverages available to companies, as well as what underwriting teams need, in order to secure the right coverages for his clients.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Yuriy Blokhin.

Yuriy is the Founder and CEO of Homecoming, which is a platform that gives coaches and therapists the tools to do their most impactful work.

In this episode, Yuriy talks about his inspiration and why he feels so passionate about the intersection between technology and mental health.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Jeremy Gardner.

Jeremy is the Founder and Managing Partner of Mystic Ventures.

In this episode, Jeremy talks about his interest in psychedelics, his history with cryptocurrencies, and how he sees the future playing out.

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Olivia Mannix.

Olivia is an award-winning entrepreneur and cannabis & psychedelics business pioneer. Olivia is the intuitive leader of marketing and the business revolution. She founded one of the first ancillary cannabis companies, Cannabrand in 2013. Being the innovator behind the movement to destigmatize cannabis and psychedelics, she recognized these opportunities long before they were widely accepted. She has founded several other companies including a tech SaS platform and sales application. She founded the first female psychedelics biotech company for women’s health: Felicity Pharma, and is one of the only women-CEOs in this space. Olivia has been recognized by Forbes, PRWeek's Top 50 Innovators, Adweek's Young Influentials and is a contributor to Adweek and Rolling Stone.

On the season three premiere of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Joël Brierre.

Joel Brierre is the Founder and CEO of the psychedelic wellness companies Kaivalya Kollectiv and Tandava Retreats, as well as co-founder of the 5-MeO-DMT education and training platform, F.I.V.E.. Joel has been a leader in the modern psychedelic movement, specifically in the realm of 5-MeO-DMT and the Bufo Alvarius toad, and has spent years helping to create safe and effective protocols around this molecule. With a passion for preparation and integration protocols, Joel and his team are involved in everything from clinical research and trainings to experiential retreats in Mexico and Jamaica.

Logan Lenz is the CEO of Nucleus, a venture studio creating brands in the psychedelics industry. Nucleus is currently raising funds through crowdfunding on Wefunder, and allowing anyone to invest in their portfolio of twelve brands with as little as $200. 

As a much-needed disclaimer, Nucleus owns and operates Psychedelic Invest.

On this episode of the Psychedelic Invest Podcast, we welcome Tim Schlidt of Palo Santo.

Palo Santo is a leading therapeutics investment fund dedicated to increasing the global supply of clinically effective and accessible healthcare solutions.

Tim is a Co-Founder and Partner of the fund, sits on the Board of many psychedelics companies, and recently closed a $50 million fund.

Tune in to learn more about Palo Santo's investment thesis, portfolio, and goals for the future of psychedelic-assisted therapies and beyond.

On this episode of the Psychedelic Invest Podcast, we welcome Anand Shahi of BAR Capital.

BAR Capital is a family office focused on continuously raising the standards of excellence for the stewardship of wealth.

Tune in to learn more about how the cannabis industry relates to psychedelics and how trends and patterns might allow us to predict future outcomes. As an investor himself, Anand shines a light on how these comparisons can lead to investment opportunities now and down the road.

On this episode of the Psychedelic Invest Podcast, Bruce Eckfeldt is joined by two of the co-founders of Anuma, a digital group therapeutics startup. Anuma is creating unique VR experiences for palliative care and beyond. 

Tune in to learn more about the men behind this novel idea, what the company is focusing on now, and how their work is positioned relative to the psychedelics industry as a whole.